Expanding indications for permanent pacemakers

Annals of Internal Medicine

Volumn 123, Issue 6, 1995, Pages 443-451

  Glikson, Michael ^a,b   Espinosa, Raul E ^a   Hayes, Avid L ^a  

^a MAYO CLINIC   (United States)

^b SHEBA MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL HEART PACEMAKER; CARDIOMYOPATHY; CONGESTIVE CARDIOMYOPATHY; DISEASE CLASSIFICATION; HEART ATRIUM FIBRILLATION; HEART TRANSPLANTATION; HEMODYNAMICS; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; LONG QT SYNDROME; PRIORITY JOURNAL; REVIEW; SYNCOPE;

EID: 0029090253     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-123-6-199509150-00009     Document Type: Review

References (82)

1. Wynne J, Braunwald E. The cardiomyopathies and myocarditides: toxic, chemical, and physical damage to the heart. In: Braunwald E, ed. Heart Disease: A Textbook of Cardiovascular Medicine. 4th edition. Philadelphia: W B Saunders; 1992:1394-1450.
2. Gilgenkrantz JM, Cherrier F, Petitier H, Dodinot B, Houplon M, Legoux J. Cardiomyopathie obstructive du ventricule gauche avec bloc auriculo-ventriculaire complet: considérations thérapeutiques. [Obstructive cardiomyopathy of the left ventricle with complete auriculo-ventricular block. Therapeutic considerations.] Arch Mal Coeur Vaiss. 1968;61:439-53.
3. Fananapazir L, Cannon RO 3d, Tripodi D, Panza JV. Impact of dual-chamber permanent pacing in patients with obstructive hypertrophic cardiomyopathy with symptoms refractory to verapamil and beta-adrenergic blocker therapy. Circulation. 1992;85:2149-61.
4. McAreavey D, Fananapazir L. Altered cardiac hemodynamic and electrical state in normal sinus rhythm after chronic dual-chamber pacing for relief of left ventricular outflow obstruction in hypertrophic cardiomyopathy. Am J Cardiol. 1992;70:651-6.
5. Fananapazir L, Epstein ND, Curiel RV, Panza JA, Tripodi D, McAreavey D. Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy. Evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy. Circulation. 1994;90:2731-42.
6. Jeanrenaud X, Goy JJ, Kappenberger L. Effects of dual-chamber pacing in hypertrophic obstructive cardiomyopathy. Lancet. 1992;339: 1318-23.
7. Matsumoto K, Saito J, Mukosaka K, Asano Y, Yamamoto T, Uchida M, et al. Influences of changing the pacing site on the hemodynamic improvement by DDD pacing in patients with hypertrophic obstructive cardiomyopathy [abstract]. Circulation. 1993;88 (Suppl):I-210.
8. Janosik DL, Pearson AC, Buckingham TA, Labovitz AJ, Redd RM. The hemodynamic benefit of differential atrioventricular delay intervals for sensed and paced atrial events during physiologic pacing. J Am Coll Cardiol. 1989;14:499-507.
9. Bonow RO, Frederick TM, Bacharach SL, Green MV, Goose PW, Maron BJ, et al. Atrial systole and left ventricular filling in hypertrophic cardiomyopathy: effect of verapamil. Am J Cardiol. 1983;51:1386-91.
10. Daubert C, Ritter P, Mabo P, Varin C, Leclercq C. AV delay optimization in DDD and DDDR pacing. In: Barold SS, Mugica J, eds. New Perspectives in Cardiac Pacing. Mount Kisco, NY: Futura; 1993: 259-87.
11. Faerestrand S. Noninvasive hemodynamic evaluation of pacing. In: Barold SS, Mugica J, eds. New Perspectives in Cardiac Pacing. Mount Kisco, NY: Futura; 1993:113-67.
12. Barold SS. Cardiac pacing in special and complex situations. Indications and modes of stimulation. Cardiol Clin. 1992;10:573-91.
13. Slade AK, Keeling PJ, Prasad K, Page C, McKenna WJ. Acute evaluation of DDD versus DDDR mode predicts additional benefit of rate adaptive pacing in hypertrophic cardiomyopathy [Abstract]. J Am Coll Cardiol. 1994;Suppl:10A.
14. Chang AC, McAreavey D, Tripodi D, Fananapazir L. Radiofrequency catheter atrioventricular node ablation in patients with permanent cardiac pacing systems. PACE Pacing Clin Electrophysiol. 1994;17: 65-9.
15. Gras D, De Place C, Leclercq C, Le Breton H, Mabo P, Daubert C. Obstructive hypertrophic cardiomyopathy treated by DDD pacing: the major importance of AV synchrony [Abstract], J Am Coll Cardiol. 1994;Suppl:11A.
16. Cannon RO 3d, Dilsizian V, Bonow RO. Symptoms, hemodynamic and myocardial benefit of atrial-synchronized ventricular pacing in nonobstructive hypertrophic cardiomyopathy [Abstract]. J Am Coll Cardiol. 1992;19:120A.
17. Seidelin PH, Jones GA, Boon NA. Effects of dual-chamber pacing in hypertrophic cardiomyopathy without obstruction [Letter]. Lancet. 1992;340:369.
18. Hochleitner M, Hortnagl H, Hortnagl H, Fridrich L, Gschnitzer F. Long-term efficacy of physiologic dual-chamber pacing in the treatment of end-stage idiopathic dilated cardiomyopathy. Am J Cardiol. 1992;70:1320-5.
19. Hochleitner M, Hortnagl H, Ng CK, Hortnagl H, Gschnitzer F, Zechmann W. Usefulness of physiologic dual-chamber pacing in drugresistant idiopathic dilated cardiomyopathy. Am J Cardiol. 1990;66: 198-202.
20. Brecker SJ, Xiao HB, Sparrow J, Gibson DG. Effects of dual-chamber pacing with short atrioventricular delay in dilated cardiomyopathy. Lancet. 1992;340:1308-12.
21. Hochleitner M, Fridrich L, Gschnitzer F. Dual-chamber pacing in dilated cardiomyopathy [Letter]. Lancet. 1993;341:629.
22. Auricchio A, Sommariva L, Salo RW, Scafuri A, Chiariello L. Improvement of cardiac function in patients with severe congestive heart failure and coronary artery disease by dual chamber pacing with shortened AV delay. PACE Pacing Clin Electrophysiol. 1993;16:2034-43.
23. Freedman RA, Yock PG, Echt DS, Popp RL. Effect of variation in PQ interval on patterns of atrioventricular valve motion and flow in patients with normal ventricular function. J Am Coll Cardiol. 1986;7:595-602.
24. Ronaszeki A, Ector H, Denef B, Aubert AE, de Werf V, de Geest H. Effect of short atrioventricular delay on cardiac output. PACE Pacing Clin Electrophysiol. 1990;13 (12 Pt 2):1728-31.
25. Harper GR, Pina IL, Kutalek SP. Intrinsic conduction maximizes cardiopulmonary performance in patients with dual chamber pacemakers. PACE Pacing Clin Electrophysiol. 1991;14:1787-91.
26. Rosenqvist M, Bergfeldt L, Haga Y, Rydén J, Öwall A, Rydén L. High right septal pacing in complete heart block is possible and improves left ventricular performance [Abstract]. Circulation. 1993;88 (Suppl): I-19.
27. Feliciano Z, Fisher ML, Gottlieb SS, Gold MR. Does short A-V delay pacing improve congestive heart failure? [Abstract]. Circulation. 1993;88 (Suppl):I-19.
28. Hesselson AB, Parsonnet V, Bernstein AD, Bonavita GJ. Deleterious effects of long-term single-chamber ventricular pacing in patients with sick sinus syndrome: the hidden benefits of dual-chamber pacing. J Am Coll Cardiol. 1992;19:1542-9.
29. Andersen HR, Thuesen L, Bagger JP, Vesterlund T, Bloch Thomsen PE. Atrial versus ventricular pacing in sick sinus syndrome. A prospective randomized trial in 225 consecutive patients [Abstract]. Eur Heart J. 1993;14 (Abstract Suppl):252.
30. Hayes DL, Neubauer SA. Incidence of atrial fibrillation after DDD pacing [Abstract]. PACE Pacing Clin Electrophysiol. 1990;13:501.
31. Gross JN, Sackstein RD, Furman S. Cardiac pacing and atrial arrhythmias. Cardiol Clin. 1992;10:609-17.
32. Attuel P, Pellerin D, Mugica J, Coumel P. DDD pacing: an effective treatment modality for recurrent atrial arrhythmias. PACE Pacing Clin Electrophysiol. 1988;11:1647-54.
33. Bellocci F, Nobile A, Spampinato A, Morelli M, de Ciuceis P, Sacchetti O, et al. Antiarrhythmic effects of DDD rate responsive pacing [Abstract]. PACE Pacing Clin Electrophysiol. 1991;14:622.
34. Kato R, Terasawa T, Gotoh T, Suzuki M. Antiarrhythmic efficacy of atrial demand (AAI) and rate responsive atrial pacing. In: Santini M, Pistolese M, Alliegro A, eds. Proceedings of the International Symposium on Progress in Clinical Pacing. Princeton: Excerpta Medica; 1988:15-24.
35. Coumel P, Friocourt P, Mugica J, Attuel P, Leclercq JF. Long-term prevention of vagal atrial arrhythmias by atrial pacing at 90/minute: experience with 6 cases. PACE Pacing Clin Electrophysiol. 1983;6:552-60.
36. Sutton R. Pacing in atrial arrhythmias. PACE Pacing Clin Electrophysiol. 1990;13:1823.
37. Bayes de Luna A, Cladellas M, Oter R, Torner P, Guindo J, Marti V, et al. Interatrial conduction block and retrograde activation of the left atrium and paroxysmal supraventricular tachyarrhythmia. Eur Heart J. 1988;9:1112-8.
38. Mabo P, Berder V, Ritter P, Paillard F, Kermarrec A, Daubert C. Prevention of atrial tachyarrhythmias related to advanced interatrial block by permanent atrial resynchronization [Abstract]. PACE Pacing Clin Electrophysiol. 1991;14:648.
39. Daubert C, Mabo P, Berder V, Le Breton H, Leclercq C, Gras D. Permanent dual atrium pacing in major interatrial conduction block: a four years experience [Abstract]. PACE Pacing Clin Electrophysiol. 1993;16:885.
40. Daubert C, Mabo P, Berder V, De Place C, Kermarrec A, Paillard F. Simultaneous dual atrium pacing in high degree interatrial blocks: hemodynamic results [Abstract]. Circulation. 1991;84 (Suppl):II-453.
41. Mackintosh AF, Carmichael DJ, Wren C, Cory-Pearce R, English TA. Sinus node function in first three weeks after cardiac transplantation. Br Heart J. 1982;48:584-8.
42. Bexton RS, Nathan AW, Hellestrand KJ, Cory-Pearce R, Spurrell RA, English TA, et al. Sinoatrial function after cardiac transplantation. J Am Coll Cardiol. 1984;3:712-23.
43. Jacquet L, Ziady G, Stein K, Griffith B, Armitage J, Hardesty R, et al. Cardiac rhythm disturbances early after orthotopic heart transplantation: prevalence and clinical importance of the observed abnormalities. J Am Coll Cardiol. 1990;16:832-7.
44. Heinz G, Ohner T, Laufer G, Gasic S, Laczkovics A. Clinical and electrophysiologic correlates of sinus node dysfunction after orthotopic heart transplantation. Observations in 42 patients. Chest. 1990;97: 890-5.
45. Markewitz A, Schmoeckel M, Nollert G, Uberfuhr P, Weinhold C, Reichart B. Long-term results of pacemaker therapy after orthotopic heart transplantation. J Card Surg. 1993;8:411-6.
46. DiBiase A, Tse TM, Schnittger I, Wexler L, Stinson EB, Valantine HA. Frequency and mechanism of bradycardia in cardiac transplant recipients and need for pacemakers. Am J Cardiol. 1991;67:1385-9.
47. Payne ME, Murray KD, Watson KM, Galbraith TA, Horwanitz EP, Starling RC, et al. Permanent pacing in heart transplant recipients: underlying causes and long-term results. J Heart Lung Transplant. 1991;10:738-42.
48. Montero JA, Anguita M, Concha M, Villarrubia A, Garcia J, Arizon JM, et al. Pacing requirements after orthotopic heart transplantation: incidence and related factors. J Heart Lung Transplant. 1992;11:799-802.
49. Miyamoto Y, Curtiss EI, Kormos RL, Armitage JM, Hardesty RL, Griffith BP. Bradyarrhythmia after heart transplantation. Incidence, time course, and outcome. Circulation. 1990;82 (Suppl 5):IV313-7.
50. Cooper MM, Smith CR, Rose EA, Schneller SJ, Spotnitz HM. Permanent pacing following cardiac transplantation. J Thorac Cardiovasc Surg. 1992;104:812-6.
51. Schmid C, Wahlers T, Schafers HJ, Haverich A. Supraventricular bradycardia after heart transplantation-orciprenaline or pacemaker implantation? Thorac Cardiovasc Surg. 1993;41:101-3.
52. Blanche C, Czer LS, Trento A, Fishbein MC, Doan D, Jordan S, et al. Bradyarrhythmias requiring pacemaker implantation after orthotopic heart transplantation: association with rejection. J Heart Lung Transplant. 1992;11:446-52.
53. Ellenbogen KA, Szentpetery S, Katz MR. Reversibility of prolonged chronotropic dysfunction with theophylline following orthotopic cardiac transplantation. Am Heart J. 1988;116:202-6.
54. Scott CD, Dark JH, McComb JM. Bradyarrhythmias requiring pacemaker implantation after orthotopic heart transplantation: association with rejection [Letter]. J Heart Lung Transplant. 1993;12:534-6.
55. Bexton RS, Nathan AW, Hellestrand KJ, Cory-Pearce R, Spurrell RA, English TA, et al. Electrophysiological abnormalities in the transplanted human heart. Br Heart J. 1983;50:555-63.
56. Marti V, Ballester M, Oter R, Obrador D, Bayes-De Luna A. Recovery of sinus node function after pacemaker implant for sinus node disease following cardiac transplantation. PACE Pacing Clin Electrophysiol. 1991;14:1205-8.
57. Scott CD, Omar I, McComb JM, Dark JH, Bexton RS. Long-term pacing in heart transplant recipients is usually unnecessary. PACE Pacing Clin Electrophysiol. 1991;14:1792-6.
58. Scott CD, McComb JM, Dark JH, Bexton RS. Permanent pacing after cardiac transplantation. Br Heart J. 1993;69:399-403.
59. Heinz G, Kratocbwill C, Buxbaum P, Kreiner G, Laufer G, Gossinger H, et al. Long-term intrinsic pacemaker function in patients paced for sinus node deficiency after cardiac transplantation. PACE Pacing Clin Electrophysiol. 1992;15:2061-7.
60. Heinz G, Kratochwill C, Hirscbl M, Buxbaum P, Kreiner G, Gasic S, et al. Normal AV node function in patients with sinus node dysfunction after cardiac transplantation. J Card Surg. 1993;8:417-24.
61. Loria K, Salinger M, McDonough T, Frohlich T, Arentzen C. Activitrax AAIR pacing for sinus node dysfunction after orthotopic heart transplantation: an initial report. J Heart Transplant. 1988;7:380-4.
62. Markewitz A, Osterholzer G, Weinhold C, Kemkes BM, Feruglio GA. Recipient P wave synchronized pacing of the donor atrium in a heart-transplanted patient: a case study. PACE Pacing Clin Electrophysiol. 1988;11:1402-4.
63. Kacet S, Molin F, Lacroix D, Prat A, Pol A, Warembourg H, et al. Bipolar atrial triggered pacing to restore normal chronotropic responsiveness in an orthotopic cardiac transplant patient. PACE Pacing Clin Electrophysiol. 1991;14:1444-7.
64. Parry G, Malbut K, Dark JH, Bexton RS. Optimal pacing modes after cardiac transplantation: is synchronisation of recipient and donor atria beneficial? Br Heart J. 1992;68:195-8.
65. Brinker JA. Optimal pacing mode in specific situations: coronary artery disease, cardiomyopathy, and cardiac transplantation. In: Barold SS, Mugica J, eds. New Perspectives in Cardiac Pacing. Mount Kisco, NY: Futura; 1993:519-46.
66. Schwartz PJ, Locati E, Priori SG, Zaza A. The long Q-T syndrome. In: Zipes DP, Jalife J, eds. Cardiac Electrophysiology From Cell to Bedside. Philadelphia: WB Saunders; 1990:589-605.
67. DiSegni E, Klein HO, David D, Libbaber C, Kaplinsky E. Overdrive pacing in quinidine syncope and other long QT-interval syndromes. Arch Intern Med. 1980;140:1036-40.
68. Moss AJ, Schwartz PJ, Crampton RS, Tzivoni D, Locati EH, MacCluer J, et al. The long QT syndrome. Prospective longitudinal study of 328 families. Circulation. 1991;84:1136-44.
69. Garson A Jr, Dick M 2d, Fournier A, Gillette PC, Hamilton R, Kugler JD, et al. The long QT syndrome in children. An international study of 287 patients. Circulation. 1993;87:1866-72.
70. Eldar M, Griffin JC, Abbott JA, Benditt D, Bhandari A, Herre JM, et al. Permanent cardiac pacing in patients with the long QT syndrome. J Am Coll Cardiol. 1987;10:600-7.
71. Eldar M, Griffin JC, Van Hare GF, Witherell C, Bhandari A, Benditt D, et al. Combined use of beta-adrenergic blocking agents and long-term cardiac pacing for patients with the long QT syndrome. J Am Coll Cardiol. 1992;20:830-7.
72. Moss AJ, Liu JE, Gottlieb S, Locati EH, Schwartz PJ, Robinson JL. Efficacy of permanent pacing in the management of high-risk patients with long QT syndrome. Circulation. 1991;84:1524-9.
73. Dreifus LS, Fisch C, Griffin JC, Gillette PC, Mason JW, Parsonnet V. Guidelines for implantation of cardiac pacemakers and antiarrhythmia devices. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Committee on Pacemaker Implantation). J Am Coll Cardiol. 1991;18:1-13.
74. Fitzpatrick A, Theodorakis G, Ahmed R, Williams T, Sutton R. Dual chamber pacing aborts vasovagal syncope induced by head-up 60 degrees tilt. PACE Pacing Clin Electrophysiol. 1991;14:13-9.
75. Fitzpatrick A, Sutton R. Tilting towards a diagnosis in recurrent unexplained syncope. Lancet. 1989;1:658-60.
76. Morgan JM, Amer AS, Ingram A, Fitzpatrick A, Sutton R. Diagnosis and management of vasovagal syndrome [Abstract]. PACE Pacing Clin Electrophysiol. 1991;14:667.
77. Sutton R. Vasovagal syncope: clinical presentation, classification and management. In: Aubert AE, Ector H, Stroobandt R, eds. Cardiac Pacing and Electrophysiology: A Bridge to the 21st Century. Boston: Klüwer; 1994:15-22.
78. Fitzpatrick AP, Travill CM, Vardas PE, Hubbard WN, Wood A, Ingram A, et al. Recurrent symptoms after ventricular pacing in unexplained syncope. PACE Pacing Clin Electrophysiol. 1990;13:619-24.
79. Sra JS, Jazayeri MK, Avitall B, Dhala A, Deshpande S, Blanck Z, et al. Comparison of cardiac pacing with drug therapy in the treatment of neurocardiogenic (vasovagal) syncope with bradycardia or asystole. N Engl J Med. 1993;328:1085-90.
80. Sutton R, Petersen M, Brignole M, Raviele A, Menozzi C, Giani P. Proposed classification for tilt induced vasovagal syncope. Eur J Cardiac Pacing Electrophysiol. 1992;2:180-3.
81. Is dual-chamber pacing efficacious in treatment of neurally-mediated tilt positive cardioinhibitory syncope? Pacemaker vs no therapy: a multicentre randomised study. Vasovagal Syncope International Study. Eur J Cardiac Pacing Electrophysiol. 1993;3:169-72.
82. Benditt DG, Petersen M, Lurie KG, Grubb BP, Sutton R. Cardiac pacing for prevention of recurrent vasovagal syncope. Ann Intern Med. 1995;122:204-9.